Azelaic	O
acid	O
is	O
used	O
to	O
treat	O
mild	O
to	O
moderate	O
acne	O
,	O
both	O
comedonal	O
acne	O
and	O
inflammatory	DISEASE
acne	DISEASE
.	O
It	O
belongs	O
to	O
a	O
class	O
of	O
medication	O
called	O
dicarboxylic	MEDICINE
acids	MEDICINE
.	O
It	O
works	O
by	O
killing	O
acne	O
bacteria	O
that	O
infect	O
skin	O
pores	O
.	O
It	O
also	O
decreases	O
the	O
production	O
of	O
keratin	O
,	O
which	O
is	O
a	O
natural	O
substance	O
that	O
promotes	O
the	O
growth	O
of	O
acne	O
bacteria	O
.	O
Azelaic	MEDICINE
acid	MEDICINE
is	O
also	O
used	O
as	O
atopical	O
gel	O
treatment	O
for	O
rosacea	DISEASE
,	O
due	O
to	O
its	O
ability	O
to	O
reduce	O
inflammation	DISEASE
.	O
It	O
clears	O
the	O
bumps	O
and	O
swelling	O
caused	O
by	O
rosacea	MEDICINE
.	O
The	O
mechanism	O
of	O
action	O
is	O
thought	O
to	O
be	O
through	O
the	O
inhibition	O
of	O
hyperactive	O
protease	O
activity	O
that	O
converts	O
cathelicidin	O
into	O
the	O
antimicrobial	O
skinpeptide	O
LL-37	O
.	O
Azelaic	MEDICINE
acid	MEDICINE
has	O
been	O
used	O
for	O
treatment	O
of	O
skin
pigmentation	O
including	O
melasma	O
and	O
post
inflammatory	O
hyper
pigmentation	O
,	O
particularly	O
in	O
those	O
with	O
darker	O
skin	O
types	O
.	O
It	O
has	O
been	O
recommended	O
as	O
analternative	O
to	O
hydroquinone	O
.	O
As	O
a	O
tyrosinase	O
inhibitor	O
,	O
azelaic	MEDICINE
acid	MEDICINE
reduces	O
synthesis	O
of	O
melanin	O
.	O
